Global Herpangina Treatment Market Growth 2022-2028
Herpangina is a type of infection that causes small blisters in mouth and throat, usually caused by a group of viruses known as enteroviruses. It is often misdiagnosed as another condition affecting children, called hand-foot-mouth disease (HFM). These both disorders cause oral blisters and ulcers but the location is slightly different. This infection is highly contagious and can easily spread person to person. This condition is not so common in adults as they have already built up the antibodies to fight the virus.
The global market for Herpangina Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Herpangina Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Herpangina Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Herpangina Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Herpangina Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Herpangina Treatment players cover Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, AstraZeneca and Abbvie, Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Herpangina Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Herpangina Treatment market, with both quantitative and qualitative data, to help readers understand how the Herpangina Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Herpangina Treatment market and forecasts the market size by Type (Coxsackievirus A, Coxsackievirus B and Enterovirus 71), by Application (Hospitals, Specialty Clinics and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Coxsackievirus A
Coxsackievirus B
Enterovirus 71
Echovirus
Segmentation by application
Hospitals
Specialty Clinics
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hoffmann-La Roche Ltd
Takeda Pharmaceutical Company Limited
Pfizer Inc
AstraZeneca
Abbvie, Inc
Bausch Health Companies Inc
Bristol Myers Squibb Company
GSK Plc
Mylan N.V
Novartis AG
Gilead Sciences, Inc
Johnson & Johnson Private Limited
Merck & Co., Inc
Vertex Pharmaceuticals Incorporated
ViiV Healthcare group of companies
Sanofi
Mitsubishi Chemical Group Corporation
Chapter Introduction
Chapter 1: Scope of Herpangina Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Herpangina Treatment market size (sales and revenue) and CAGR, Herpangina Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Herpangina Treatment sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Herpangina Treatment sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Herpangina Treatment market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, AstraZeneca, Abbvie, Inc, Bausch Health Companies Inc, Bristol Myers Squibb Company, GSK Plc and Mylan N.V, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herpangina Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Herpangina Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Herpangina Treatment by Country/Region, 2017, 2022 & 2028
2.2 Herpangina Treatment Segment by Type
2.2.1 Coxsackievirus A
2.2.2 Coxsackievirus B
2.2.3 Enterovirus 71
2.2.4 Echovirus
2.3 Herpangina Treatment Sales by Type
2.3.1 Global Herpangina Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Herpangina Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Herpangina Treatment Sale Price by Type (2017-2022)
2.4 Herpangina Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Other
2.5 Herpangina Treatment Sales by Application
2.5.1 Global Herpangina Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Herpangina Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Herpangina Treatment Sale Price by Application (2017-2022)
3 Global Herpangina Treatment by Company
3.1 Global Herpangina Treatment Breakdown Data by Company
3.1.1 Global Herpangina Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Herpangina Treatment Sales Market Share by Company (2020-2022)
3.2 Global Herpangina Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Herpangina Treatment Revenue by Company (2020-2022)
3.2.2 Global Herpangina Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Herpangina Treatment Sale Price by Company
3.4 Key Manufacturers Herpangina Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herpangina Treatment Product Location Distribution
3.4.2 Players Herpangina Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Herpangina Treatment by Geographic Region
4.1 World Historic Herpangina Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Herpangina Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Herpangina Treatment Annual Revenue by Geographic Region
4.2 World Historic Herpangina Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Herpangina Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Herpangina Treatment Annual Revenue by Country/Region
4.3 Americas Herpangina Treatment Sales Growth
4.4 APAC Herpangina Treatment Sales Growth
4.5 Europe Herpangina Treatment Sales Growth
4.6 Middle East & Africa Herpangina Treatment Sales Growth
5 Americas
5.1 Americas Herpangina Treatment Sales by Country
5.1.1 Americas Herpangina Treatment Sales by Country (2017-2022)
5.1.2 Americas Herpangina Treatment Revenue by Country (2017-2022)
5.2 Americas Herpangina Treatment Sales by Type
5.3 Americas Herpangina Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herpangina Treatment Sales by Region
6.1.1 APAC Herpangina Treatment Sales by Region (2017-2022)
6.1.2 APAC Herpangina Treatment Revenue by Region (2017-2022)
6.2 APAC Herpangina Treatment Sales by Type
6.3 APAC Herpangina Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Herpangina Treatment by Country
7.1.1 Europe Herpangina Treatment Sales by Country (2017-2022)
7.1.2 Europe Herpangina Treatment Revenue by Country (2017-2022)
7.2 Europe Herpangina Treatment Sales by Type
7.3 Europe Herpangina Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Herpangina Treatment by Country
8.1.1 Middle East & Africa Herpangina Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Herpangina Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Herpangina Treatment Sales by Type
8.3 Middle East & Africa Herpangina Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Herpangina Treatment
10.3 Manufacturing Process Analysis of Herpangina Treatment
10.4 Industry Chain Structure of Herpangina Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Herpangina Treatment Distributors
11.3 Herpangina Treatment Customer
12 World Forecast Review for Herpangina Treatment by Geographic Region
12.1 Global Herpangina Treatment Market Size Forecast by Region
12.1.1 Global Herpangina Treatment Forecast by Region (2023-2028)
12.1.2 Global Herpangina Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Herpangina Treatment Forecast by Type
12.7 Global Herpangina Treatment Forecast by Application
13 Key Players Analysis
13.1 Hoffmann-La Roche Ltd
13.1.1 Hoffmann-La Roche Ltd Company Information
13.1.2 Hoffmann-La Roche Ltd Herpangina Treatment Product Offered
13.1.3 Hoffmann-La Roche Ltd Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hoffmann-La Roche Ltd Main Business Overview
13.1.5 Hoffmann-La Roche Ltd Latest Developments
13.2 Takeda Pharmaceutical Company Limited
13.2.1 Takeda Pharmaceutical Company Limited Company Information
13.2.2 Takeda Pharmaceutical Company Limited Herpangina Treatment Product Offered
13.2.3 Takeda Pharmaceutical Company Limited Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.2.5 Takeda Pharmaceutical Company Limited Latest Developments
13.3 Pfizer Inc
13.3.1 Pfizer Inc Company Information
13.3.2 Pfizer Inc Herpangina Treatment Product Offered
13.3.3 Pfizer Inc Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Inc Main Business Overview
13.3.5 Pfizer Inc Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Herpangina Treatment Product Offered
13.4.3 AstraZeneca Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Abbvie, Inc
13.5.1 Abbvie, Inc Company Information
13.5.2 Abbvie, Inc Herpangina Treatment Product Offered
13.5.3 Abbvie, Inc Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abbvie, Inc Main Business Overview
13.5.5 Abbvie, Inc Latest Developments
13.6 Bausch Health Companies Inc
13.6.1 Bausch Health Companies Inc Company Information
13.6.2 Bausch Health Companies Inc Herpangina Treatment Product Offered
13.6.3 Bausch Health Companies Inc Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bausch Health Companies Inc Main Business Overview
13.6.5 Bausch Health Companies Inc Latest Developments
13.7 Bristol Myers Squibb Company
13.7.1 Bristol Myers Squibb Company Company Information
13.7.2 Bristol Myers Squibb Company Herpangina Treatment Product Offered
13.7.3 Bristol Myers Squibb Company Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bristol Myers Squibb Company Main Business Overview
13.7.5 Bristol Myers Squibb Company Latest Developments
13.8 GSK Plc
13.8.1 GSK Plc Company Information
13.8.2 GSK Plc Herpangina Treatment Product Offered
13.8.3 GSK Plc Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GSK Plc Main Business Overview
13.8.5 GSK Plc Latest Developments
13.9 Mylan N.V
13.9.1 Mylan N.V Company Information
13.9.2 Mylan N.V Herpangina Treatment Product Offered
13.9.3 Mylan N.V Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan N.V Main Business Overview
13.9.5 Mylan N.V Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Herpangina Treatment Product Offered
13.10.3 Novartis AG Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 Gilead Sciences, Inc
13.11.1 Gilead Sciences, Inc Company Information
13.11.2 Gilead Sciences, Inc Herpangina Treatment Product Offered
13.11.3 Gilead Sciences, Inc Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Gilead Sciences, Inc Main Business Overview
13.11.5 Gilead Sciences, Inc Latest Developments
13.12 Johnson & Johnson Private Limited
13.12.1 Johnson & Johnson Private Limited Company Information
13.12.2 Johnson & Johnson Private Limited Herpangina Treatment Product Offered
13.12.3 Johnson & Johnson Private Limited Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Johnson & Johnson Private Limited Main Business Overview
13.12.5 Johnson & Johnson Private Limited Latest Developments
13.13 Merck & Co., Inc
13.13.1 Merck & Co., Inc Company Information
13.13.2 Merck & Co., Inc Herpangina Treatment Product Offered
13.13.3 Merck & Co., Inc Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Merck & Co., Inc Main Business Overview
13.13.5 Merck & Co., Inc Latest Developments
13.14 Vertex Pharmaceuticals Incorporated
13.14.1 Vertex Pharmaceuticals Incorporated Company Information
13.14.2 Vertex Pharmaceuticals Incorporated Herpangina Treatment Product Offered
13.14.3 Vertex Pharmaceuticals Incorporated Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Vertex Pharmaceuticals Incorporated Main Business Overview
13.14.5 Vertex Pharmaceuticals Incorporated Latest Developments
13.15 ViiV Healthcare group of companies
13.15.1 ViiV Healthcare group of companies Company Information
13.15.2 ViiV Healthcare group of companies Herpangina Treatment Product Offered
13.15.3 ViiV Healthcare group of companies Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 ViiV Healthcare group of companies Main Business Overview
13.15.5 ViiV Healthcare group of companies Latest Developments
13.16 Sanofi
13.16.1 Sanofi Company Information
13.16.2 Sanofi Herpangina Treatment Product Offered
13.16.3 Sanofi Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sanofi Main Business Overview
13.16.5 Sanofi Latest Developments
13.17 Mitsubishi Chemical Group Corporation
13.17.1 Mitsubishi Chemical Group Corporation Company Information
13.17.2 Mitsubishi Chemical Group Corporation Herpangina Treatment Product Offered
13.17.3 Mitsubishi Chemical Group Corporation Herpangina Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Mitsubishi Chemical Group Corporation Main Business Overview
13.17.5 Mitsubishi Chemical Group Corporation Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Herpangina Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Herpangina Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Coxsackievirus A
Table 4. Major Players of Coxsackievirus B
Table 5. Major Players of Enterovirus 71
Table 6. Major Players of Echovirus
Table 7. Global Herpangina Treatment Sales by Type (2017-2022) & (K Units)
Table 8. Global Herpangina Treatment Sales Market Share by Type (2017-2022)
Table 9. Global Herpangina Treatment Revenue by Type (2017-2022) & ($ million)
Table 10. Global Herpangina Treatment Revenue Market Share by Type (2017-2022)
Table 11. Global Herpangina Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Herpangina Treatment Sales by Application (2017-2022) & (K Units)
Table 13. Global Herpangina Treatment Sales Market Share by Application (2017-2022)
Table 14. Global Herpangina Treatment Revenue by Application (2017-2022)
Table 15. Global Herpangina Treatment Revenue Market Share by Application (2017-2022)
Table 16. Global Herpangina Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Herpangina Treatment Sales by Company (2020-2022) & (K Units)
Table 18. Global Herpangina Treatment Sales Market Share by Company (2020-2022)
Table 19. Global Herpangina Treatment Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Herpangina Treatment Revenue Market Share by Company (2020-2022)
Table 21. Global Herpangina Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Herpangina Treatment Producing Area Distribution and Sales Area
Table 23. Players Herpangina Treatment Products Offered
Table 24. Herpangina Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Herpangina Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Herpangina Treatment Sales Market Share Geographic Region (2017-2022)
Table 29. Global Herpangina Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Herpangina Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Herpangina Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Herpangina Treatment Sales Market Share by Country/Region (2017-2022)
Table 33. Global Herpangina Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Herpangina Treatment Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Herpangina Treatment Sales by Country (2017-2022) & (K Units)
Table 36. Americas Herpangina Treatment Sales Market Share by Country (2017-2022)
Table 37. Americas Herpangina Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Herpangina Treatment Revenue Market Share by Country (2017-2022)
Table 39. Americas Herpangina Treatment Sales by Type (2017-2022) & (K Units)
Table 40. Americas Herpangina Treatment Sales Market Share by Type (2017-2022)
Table 41. Americas Herpangina Treatment Sales by Application (2017-2022) & (K Units)
Table 42. Americas Herpangina Treatment Sales Market Share by Application (2017-2022)
Table 43. APAC Herpangina Treatment Sales by Region (2017-2022) & (K Units)
Table 44. APAC Herpangina Treatment Sales Market Share by Region (2017-2022)
Table 45. APAC Herpangina Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Herpangina Treatment Revenue Market Share by Region (2017-2022)
Table 47. APAC Herpangina Treatment Sales by Type (2017-2022) & (K Units)
Table 48. APAC Herpangina Treatment Sales Market Share by Type (2017-2022)
Table 49. APAC Herpangina Treatment Sales by Application (2017-2022) & (K Units)
Table 50. APAC Herpangina Treatment Sales Market Share by Application (2017-2022)
Table 51. Europe Herpangina Treatment Sales by Country (2017-2022) & (K Units)
Table 52. Europe Herpangina Treatment Sales Market Share by Country (2017-2022)
Table 53. Europe Herpangina Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Herpangina Treatment Revenue Market Share by Country (2017-2022)
Table 55. Europe Herpangina Treatment Sales by Type (2017-2022) & (K Units)
Table 56. Europe Herpangina Treatment Sales Market Share by Type (2017-2022)
Table 57. Europe Herpangina Treatment Sales by Application (2017-2022) & (K Units)
Table 58. Europe Herpangina Treatment Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Herpangina Treatment Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Herpangina Treatment Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Herpangina Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Herpangina Treatment Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Herpangina Treatment Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Herpangina Treatment Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Herpangina Treatment Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Herpangina Treatment Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Herpangina Treatment
Table 68. Key Market Challenges & Risks of Herpangina Treatment
Table 69. Key Industry Trends of Herpangina Treatment
Table 70. Herpangina Treatment Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Herpangina Treatment Distributors List
Table 73. Herpangina Treatment Customer List
Table 74. Global Herpangina Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Herpangina Treatment Sales Market Forecast by Region
Table 76. Global Herpangina Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Herpangina Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Herpangina Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Herpangina Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Herpangina Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Herpangina Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Herpangina Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Herpangina Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Herpangina Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Herpangina Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Herpangina Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Herpangina Treatment Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Herpangina Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Herpangina Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Herpangina Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Herpangina Treatment Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Herpangina Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Herpangina Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 94. Hoffmann-La Roche Ltd Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Hoffmann-La Roche Ltd Herpangina Treatment Product Offered
Table 96. Hoffmann-La Roche Ltd Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Hoffmann-La Roche Ltd Main Business
Table 98. Hoffmann-La Roche Ltd Latest Developments
Table 99. Takeda Pharmaceutical Company Limited Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Takeda Pharmaceutical Company Limited Herpangina Treatment Product Offered
Table 101. Takeda Pharmaceutical Company Limited Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Takeda Pharmaceutical Company Limited Main Business
Table 103. Takeda Pharmaceutical Company Limited Latest Developments
Table 104. Pfizer Inc Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Inc Herpangina Treatment Product Offered
Table 106. Pfizer Inc Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Pfizer Inc Main Business
Table 108. Pfizer Inc Latest Developments
Table 109. AstraZeneca Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Herpangina Treatment Product Offered
Table 111. AstraZeneca Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Abbvie, Inc Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Abbvie, Inc Herpangina Treatment Product Offered
Table 116. Abbvie, Inc Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Abbvie, Inc Main Business
Table 118. Abbvie, Inc Latest Developments
Table 119. Bausch Health Companies Inc Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 120. Bausch Health Companies Inc Herpangina Treatment Product Offered
Table 121. Bausch Health Companies Inc Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Bausch Health Companies Inc Main Business
Table 123. Bausch Health Companies Inc Latest Developments
Table 124. Bristol Myers Squibb Company Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 125. Bristol Myers Squibb Company Herpangina Treatment Product Offered
Table 126. Bristol Myers Squibb Company Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Bristol Myers Squibb Company Main Business
Table 128. Bristol Myers Squibb Company Latest Developments
Table 129. GSK Plc Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 130. GSK Plc Herpangina Treatment Product Offered
Table 131. GSK Plc Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. GSK Plc Main Business
Table 133. GSK Plc Latest Developments
Table 134. Mylan N.V Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 135. Mylan N.V Herpangina Treatment Product Offered
Table 136. Mylan N.V Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Mylan N.V Main Business
Table 138. Mylan N.V Latest Developments
Table 139. Novartis AG Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 140. Novartis AG Herpangina Treatment Product Offered
Table 141. Novartis AG Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Novartis AG Main Business
Table 143. Novartis AG Latest Developments
Table 144. Gilead Sciences, Inc Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 145. Gilead Sciences, Inc Herpangina Treatment Product Offered
Table 146. Gilead Sciences, Inc Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Gilead Sciences, Inc Main Business
Table 148. Gilead Sciences, Inc Latest Developments
Table 149. Johnson & Johnson Private Limited Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 150. Johnson & Johnson Private Limited Herpangina Treatment Product Offered
Table 151. Johnson & Johnson Private Limited Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Johnson & Johnson Private Limited Main Business
Table 153. Johnson & Johnson Private Limited Latest Developments
Table 154. Merck & Co., Inc Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 155. Merck & Co., Inc Herpangina Treatment Product Offered
Table 156. Merck & Co., Inc Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Merck & Co., Inc Main Business
Table 158. Merck & Co., Inc Latest Developments
Table 159. Vertex Pharmaceuticals Incorporated Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 160. Vertex Pharmaceuticals Incorporated Herpangina Treatment Product Offered
Table 161. Vertex Pharmaceuticals Incorporated Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Vertex Pharmaceuticals Incorporated Main Business
Table 163. Vertex Pharmaceuticals Incorporated Latest Developments
Table 164. ViiV Healthcare group of companies Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 165. ViiV Healthcare group of companies Herpangina Treatment Product Offered
Table 166. ViiV Healthcare group of companies Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. ViiV Healthcare group of companies Main Business
Table 168. ViiV Healthcare group of companies Latest Developments
Table 169. Sanofi Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 170. Sanofi Herpangina Treatment Product Offered
Table 171. Sanofi Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Sanofi Main Business
Table 173. Sanofi Latest Developments
Table 174. Mitsubishi Chemical Group Corporation Basic Information, Herpangina Treatment Manufacturing Base, Sales Area and Its Competitors
Table 175. Mitsubishi Chemical Group Corporation Herpangina Treatment Product Offered
Table 176. Mitsubishi Chemical Group Corporation Herpangina Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. Mitsubishi Chemical Group Corporation Main Business
Table 178. Mitsubishi Chemical Group Corporation Latest Developments
List of Figures
Figure 1. Picture of Herpangina Treatment
Figure 2. Herpangina Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herpangina Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Herpangina Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Herpangina Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Coxsackievirus A
Figure 10. Product Picture of Coxsackievirus B
Figure 11. Product Picture of Enterovirus 71
Figure 12. Product Picture of Echovirus
Figure 13. Global Herpangina Treatment Sales Market Share by Type in 2021
Figure 14. Global Herpangina Treatment Revenue Market Share by Type (2017-2022)
Figure 15. Herpangina Treatment Consumed in Hospitals
Figure 16. Global Herpangina Treatment Market: Hospitals (2017-2022) & (K Units)
Figure 17. Herpangina Treatment Consumed in Specialty Clinics
Figure 18. Global Herpangina Treatment Market: Specialty Clinics (2017-2022) & (K Units)
Figure 19. Herpangina Treatment Consumed in Other
Figure 20. Global Herpangina Treatment Market: Other (2017-2022) & (K Units)
Figure 21. Global Herpangina Treatment Sales Market Share by Application (2017-2022)
Figure 22. Global Herpangina Treatment Revenue Market Share by Application in 2021
Figure 23. Herpangina Treatment Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Herpangina Treatment Revenue Market Share by Company in 2021
Figure 25. Global Herpangina Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Herpangina Treatment Revenue Market Share by Geographic Region in 2021
Figure 27. Global Herpangina Treatment Sales Market Share by Region (2017-2022)
Figure 28. Global Herpangina Treatment Revenue Market Share by Country/Region in 2021
Figure 29. Americas Herpangina Treatment Sales 2017-2022 (K Units)
Figure 30. Americas Herpangina Treatment Revenue 2017-2022 ($ Millions)
Figure 31. APAC Herpangina Treatment Sales 2017-2022 (K Units)
Figure 32. APAC Herpangina Treatment Revenue 2017-2022 ($ Millions)
Figure 33. Europe Herpangina Treatment Sales 2017-2022 (K Units)
Figure 34. Europe Herpangina Treatment Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Herpangina Treatment Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Herpangina Treatment Revenue 2017-2022 ($ Millions)
Figure 37. Americas Herpangina Treatment Sales Market Share by Country in 2021
Figure 38. Americas Herpangina Treatment Revenue Market Share by Country in 2021
Figure 39. United States Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Herpangina Treatment Sales Market Share by Region in 2021
Figure 44. APAC Herpangina Treatment Revenue Market Share by Regions in 2021
Figure 45. China Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Herpangina Treatment Sales Market Share by Country in 2021
Figure 52. Europe Herpangina Treatment Revenue Market Share by Country in 2021
Figure 53. Germany Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Herpangina Treatment Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Herpangina Treatment Revenue Market Share by Country in 2021
Figure 60. Egypt Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Herpangina Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Herpangina Treatment in 2021
Figure 66. Manufacturing Process Analysis of Herpangina Treatment
Figure 67. Industry Chain Structure of Herpangina Treatment
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets